Biography
Dr. Erika MacDonald is a native of Moncton, New Brunswick. She obtained her B. Sc. Pharm from Dalhousie University in 2006 and completed a hospital pharmacy residency at The Ottawa Hospital in 2007. She has since been working at the Ottawa Hospital as a pharmacist in general medicine and most recently in critical care, as a Professional Practice Coordinator from 2012-2020, and then as a Clinical Pharmacy Manager and residency program coordinator since 2020. She completed an MSc in Epidemiology at the University of Ottawa in 2015, and a PharmD at the University of Toronto in 2019. Dr. Macdonald has an affiliation with the Ottawa Hospital Research Institute as a Clinician Investigator.
Expertise
- Pharmacotherapy
- Pharmacy practice
- Epidemiology
- Pharmacy Administration
Research Projects
Dr. Macdonald’s research interests include knowledge synthesis, medication safety, and pharmacy practice.
- MacDonald E, Horton J. Bupropion for major depressive disorder or persistent depressive disorder (dysthymia). Canadian Journal of Health Technologies. 2021;1(4). doi:10.51731/cjht.2021.62
- Thabet P, Joshi A, MacDonald E, et al. Clinical and pharmacokinetic/dynamic outcomes of prolonged infusions of beta-lactam antimicrobials: An overview of Systematic Reviews. PLOS ONE. 2021;16(1). doi:10.1371/journal.pone.0244966
- Ondansetron and Oral Rehydration Therapy in Pediatric Patients with Dehydration: A Review of Clinical Effectiveness. Ottawa: CADTH; 2020 Feb. (CADTH rapid response report: summary with critical appraisal). https://www.ncbi.nlm.nih.gov/books/NBK562939/
- Johnston A, Natarajan S, Hayes M, MacDonald E, Shorr R. Accelerated induction regimens of TNF-alpha inhibitors in patients with inflammatory bowel disease: A scoping review protocol. BMJ Open. 2018;8(1). doi:10.1136/bmjopen-2017-019909
- Benzydamine for the treatment of oropharyngeal mucositis from radiation therapy: A review of clinical effectiveness and guidelines. Ottawa: CADTH; 2018 Sep. (CADTH rapid response report: summary with critical appraisal). https://www.ncbi.nlm.nih.gov/books/NBK538349/
- Wentzell J, Nguyen T, Bui S, MacDonald E. Pharmacy student facilitation of reporting of adverse drug reactions in a hospital. The Canadian Journal of Hospital Pharmacy. 2017;70(4). doi:10.4212/cjhp.v70i4.1677
- Thromboelastography or Rotational Thromboelastography for Trauma: A Review of the Clinical and Cost-Effectiveness and Guidelines. Ottawa: CADTH; 2017 Sep (CADTH rapid response report: summary with critical appraisal). https://pubmed.ncbi.nlm.nih.gov/30020588/
- Hutton B, Kanji S, MacDonald E, et al. Incidence, causes, and consequences of preventable adverse drug events: Protocol for an overview of reviews. Systematic Reviews. 2016;5(1). doi:10.1186/s13643-016-0392-4
- Kanji S, Mera A, Hutton B, Burry L, Rosenberg E, MacDonald E, Luks V. Pharmacological interventions to improve sleep in hospitalised adults: a systematic review. BMJ Open. 2016;6(7). doi:10.1136/bmjopen-2016-012108
- Mihajlovic S, Gauthier J, MacDonald E. Patient characteristics associated with adverse drug events in hospital: An overview of reviews. The Canadian Journal of Hospital Pharmacy. 2016;69(4). doi:10.4212/cjhp.v69i4.1583
- MacDonald E. Exploration of post-market evidence of effectiveness and safety of TNF-alpha inhibitors in Crohn’s and colitis. 2015. https://ruor.uottawa.ca/handle/10393/33416
- Telemedicine for the Treatment of Urgent Conditions: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines. Ottawa: CADTH; 2015 Oct. (CADTH rapid response report: summary with critical appraisal). https://pubmed.ncbi.nlm.nih.gov/26561688/
- Long-term use of cyclobenzaprine for pain: A Review of the Clinical Effectiveness Canadian Association for Drugs and Technology in Health. Ottawa: CADTH; 2015 Feb. (CADTH rapid response report: summary with critical appraisal). https://www.ncbi.nlm.nih.gov/books/NBK279656/
- Jacques AC, Lougheed C, MacDonald E, Karovitch A, Giguère P. Effectiveness of unfractionated heparin in normal saline versus dextrose for achieving and maintaining therapeutic anti–factor XA levels in patients with non-st-elevation acute coronary syndrome. The Canadian Journal of Hospital Pharmacy. 2013;66(6). doi:10.4212/cjhp.v66i6.1299
- Pawlosky N, MacDonald E, Patel R, Kanji S. Evaluation of digoxin concentration after loading dose in patients with renal dysfunction. The Canadian Journal of Hospital Pharmacy. 2013;66(2). doi:10.4212/cjhp.v66i2.1232
- Kanji S, Jones E, Goddard R, Meggison HE, Neilipovitz D. Efficiency and safety of a standardized protocol for intravenous insulin therapy in ICU patients with neurovascular or head injury. Neurocritical Care. 2009;12(1):43-49. doi:10.1007/s12028-009-9275-z
- Jones E. Hold the tofu? phytoestrogens for menopausal symptoms in women with breast cancer. Canadian Pharmacists Journal. 2008;141(3):166-169. doi:10.3821/1913-701x(2008)141[166:httpfm]2.0.co;2
- Jones E. Drug-induced syndrome of inappropriate antidiuretic hormone. Canadian Pharmacists Journal. 2007;140(6):397-399. doi:10.3821/1913-701x(2007)140[397:dsoiah]2.0.co;2
- Hartnell NR, MacKinnon NJ, Jones EJM, Genge RJ, Nestel MDM. Perceptions of patients and health care professionals about factors contributing to medication errors and potential areas for improvement. Canadian Journal of Hospital Pharmacy. 2006;59(4). 177-83. https://www.cjhp-online.ca/index.php/cjhp/article/view/254/248
- MacKinnon NJ, Hartnell NR, Bowles S, Kirkland S, Jones EJM. Incident-event rate of preventable drug-related morbidity in older adults in Nova Scotia. Canadian Journal of Geriatrics. 2006;9(5):159-63. https://www.researchgate.net/publication/265248044_Incident-Event_Rate_of_Preventable_Drug-Related_Morbidity_in_Older_Adults_in_Nova_Scotia
- Jones EJM, MacKinnon NJ, Tsuyuki RT. Pharmaceutical Care in Community pharmacies: Practice and research in Canada. Annals of Pharmacotherapy. 2005;39(9):1527-1533. doi:10.1345/aph.1e456
Awards and Honours
- Award of Excellence in Graduate Studies (2014), University of Ottawa